MOSCOW (Reuters) - Bolivia has granted emergency approval for use of Russia’s Sputnik vaccine against COVID-19, Russian sovereign fund RDIF said on Wednesday.
The vaccine was registered by the Bolivian regulator based on the results of Phase III clinical trials in Russia, without additional trials in Bolivia, RDIF said in a statement.
RDIF said on Dec. 30 it had agreed to supply Bolivia with enough of its two-dose Sputnik V coronavirus vaccine to vaccinate 2.6 million people.
Reporting by Anton Kolodyazhnyy, writing by Maria Kiselyova; Editing by Gareth Jones
Our Standards: The Thomson Reuters Trust Principles.